U.S., Aug. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07773519) titled 'Effects of a 10-Week High-Intensity Interval Training Programme on Biochemical and Hormonal... Read More
Singapore, Aug. 20 -- The Health Sciences Authority received information related to the study titled 'An Open-label, Randomized, Controlled Phase 3 Study of Disitamab Vedotin in Combination with Pembr... Read More
Singapore, Aug. 20 -- The Health Sciences Authority received information related to the study titled 'A Randomized, Open-label, Phase 3 Study of Rina-S ± Bevacizumab Versus Investigator's Choice of Pl... Read More
U.S., Aug. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07773753) titled 'Validation of the Vision Trainer Clinical Decision-Support Software' on July 31. Brief Sum... Read More
U.S., Aug. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07774208) titled 'FABP4 Response After Roux-en-Y Gastric Bypass' on Aug. 12. Brief Summary: This retrospecti... Read More
U.S., Aug. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07772297) titled 'Biomarkers of Cervical Spondylotic Myelopathy' on Aug. 13. Brief Summary: We believe that ... Read More
U.S., Aug. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07772050) titled 'IV Bevacizumab Treatment of Patients With Hereditary Hemorrhagic Telangiectasia (HHT) or Re... Read More
Singapore, Aug. 20 -- The Health Sciences Authority received information related to the study titled 'ROSETTA Lung-201: A Randomized, Multicenter, Open-label Phase 3 Study of Pumitamig Monotherapy Com... Read More
U.S., Aug. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07774650) titled 'A Study of the Pharmacokinetics, Biodistribution and Dosimetry of Granzyme-B Targeted [Cu-6... Read More
Singapore, Aug. 20 -- The Health Sciences Authority received information related to the study titled 'A Phase 2, Randomized, Open-Label Study of VVD-133214 in Combination with Pembrolizumab compared w... Read More